黑料网

ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Citations : 3314

Flyer image
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
View More
Useful Links
Recommended Journals
View More
Related Subjects
View More
Share This Page

Biomaterial-Based Drug Delivery Systems

Biomaterial-based drug delivery systems utilize engineered materials to deliver therapeutic agents in a controlled and targeted manner. These systems enhance drug stability, bioavailability, and efficacy while minimizing side effects.
Biomaterial-based drug delivery systems are designed to improve the precision and effectiveness of treatments by using biocompatible materials to carry and release drugs at specific sites in the body. These systems can be tailored to respond to specific stimuli, such as pH or temperature, allowing for controlled release of medication over time. By optimizing the delivery of therapeutic agents, these systems offer significant advancements in treating diseases with greater accuracy and reduced toxicity.

Biomaterial-Based Drug Delivery Systems

Expert PPTs

Speaker PPTs

  • Sundeep Kumar Upadhyaya
    LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
    | PDF Version
  • Li Yu-Jung
    Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
    | PDF Version
  • Jonny Carlos da Silva
    Jonny-Carlos-da-Silva-Federal-University-of-Santa-Catarina-Brazil-Design-for-reliability-of-mechatronic-systems-supported-by-knowledge-based-systems-in-design-process-early-phases
    | PDF Version
  • Sitanshu Sekhar Lahiri
    A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted delivery
    | PDF Version
  • Mario Marques da Silva
    MIMO Systems and Applications
    | PDF Version
  • Elizabeth Chang
    Advances in Internet of Things and Cyber Physical Systems and its Adoption to Smart Ship
    | PDF Version
  • Carsten Worsoe
    The value of the 脙垄芒聜卢脜聯simulated study脙垄芒聜卢脗聺 as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Li-Chun Tsou
    Drug delivery device strategy for patient centric therapies
    | PDF Version
  • Dipesh Shah
    Compatibility assessment of a model monoclonal antibody formulation in glass and in blow-fi ll-seal (BFS) plastic vial delivery formats
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Panayiotis P Constantinides
    Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
    | PDF Version
  • Merve Sagiroglu
    Merve-Sag脙聞脗卤roglu- Erzurum-Technical-University-Turkey- Evaluation-of-Connection-Systems-in-Modular-Constructions
    | PDF Version
  • Arshad Islam
    Nanosystems formed by amphiphilic antimony(v) complexes incorporating amphotericin B for the treatment leishmaniasis
    | PDF Version
  • Jan Voskuil
    How antibodies can prevent medical progress and how they can be great tools?
    | PDF Version
  • Kadir Genc
    Kadir-Genc-Valeo-Automotive-Systems-Industry-Turkey-Development-of-stamping-technology-in-automotive-and-production-speed-calculations
    | PDF Version
  • Stephanie Ramos
    Enhanced Delivery of Dna-Based Vaccines and Immunotherapeutics through Next-Generation Electroporation Devices
    | PDF Version
  • Nirmala Chauhan
    Modification of dietary fiber psyllium for use in oral insulin delivery
    | PDF Version
  • Veronica La Regina
    Veronica-La-Regina-Italian-Space-Agency-(ASI)-Italy-Systems-engineering-approach-and-space-technology-transfer-The-role-of-international-relations-and-public-policy
    | PDF Version
  • Fan-Gang Tseng
    Fan-Gang-Tseng-National-Tsing-Hua-University-Taiwan-Nano-Micro-fluidic-systems-for-circulating-Tumor-Cells-(CTCs)-rapid-detection-and-diagnosis
    | PDF Version
  • Arshad mahmood
    TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Wei Duan
    Cancer stem cells targeted delivery of siRNA to overcome induced chemoresistance
    | PDF Version
  • Vivek Lal
    New drug development in type-2 diabetes mellitus : current and future trends 脙垄芒聜卢芒聙聹 an overview
    | PDF Version
  • Joan Smith Sonneborn
    Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
    | PDF Version
  • Long Liu
    Systems metabolic engineering of Bacillus subtilis for efficient N-acetyl glucosamine production
    | PDF Version
  • Barbara Klajnert-Maculewicz
    Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
    | PDF Version
  • Adel Nefzi
    脙垄芒聜卢脜聯Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery脙垄芒聜卢脗聺
    | PDF Version
  • Yung-Chih Kuo
    脙垄芒聜卢脜聯Yung-Chih Kuo-National-Chung-Cheng-University-Republic-of-China-Targeting-delivery-of-etoposide-to-inhibit-the-growth-of-human-glioblastoma-multiforme-using-lactoferrin-and-folic-acid-grafted-poly(lactide-co-glycolide)-nanoparticles脙垄芒聜卢脗聺
    | PDF Version
  • Igor Malyshev
    GENETIC FEATURES OF NO GENERATING SYSTEMS AND RESISTANT TO EHRLICH ASCITES CARCINOMA
    | PDF Version
  • Tanvir Ahmed
    Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
    | PDF Version
  • C Peter Waegemann
    What Can We Learn from the Failure of Electronic Health Record Systems?
    | PDF Version
  • Placide Poba-Nzaou
    Open Source as an Alternative for Clinical Information Systems Adoption
    | PDF Version
  • Mukesh Kumar
    Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Sevgi Gungor
    Micelles as nanosized carriers for skin delivery of drugs
    | PDF Version
  • Ru Band Lu
    Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • L C De
    Orchid- A diversified component of farming systems for profitability and livelihood security
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Anita Nair
    BCS-Based Biowaivers: Which Drugs are Eligible?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Eggehard Holler
    Biodegradable nanobrushes for drug delivery
    | PDF Version
  • Audrius Andrijauskas
    Advance in perioperative fluid therapy: from fixed volume to individual approach, from individual practices to decision-support and closed loop systems
    | PDF Version
  • Lucia Gemma Delogu
    Functionalized carbon nanotubes as immunomodulator systems and ultrasound contrast agents
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Lavinia-Oltita Br脛茠tescu
    Hepcidin-25-A useful clinical guide for iron-restricted erythropoiesis detection in haemodialysis patients
    | PDF Version
  • Navneet Sharma
    Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
  • Richard A. Kenley
    Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
    | PDF Version
  • Elena Gavrilova
    Application of drugs based on release-active antibodies as immunotherapy agents
    | PDF Version
  • William Lee
    Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
    | PDF Version
  • Krasimira Pekova
    Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
    | PDF Version
  • Erhabor Osaro
    CHALLENGES OF BLOOD TRANSFUSION SERVICE DELIVERY IN SUB SAHARAN AFRICA
    | PDF Version
  • Jasmin Kaur
    Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
    | PDF Version
  • Alexander von Gabain
    Learning from the EIT: Driving Innovation through Ecosystems that Foster Entrepreneurship
    | PDF Version
  • Matin Peters
    Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
    | PDF Version
  • Marcelo Febo
    3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
    | PDF Version
  • Bairong Shen
    Computational biomarker discovery in the big data era: From translational biomedical informatics to systems medicine
    | PDF Version
  • Jim Klostergaard
    Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
    | PDF Version
  • Sree Harsha
    Optimization of particles size for lung specific drug delivery by way of microspheres
    | PDF Version
  • Ruslan N. Grishanin
    Adeno-associated virus-mediated delivery of amyloid 脙聨脗虏 antibody for treatment of age-related retinal degenerative diseases
    | PDF Version
  • Stefanie Wienkoop
    Comprehensive Protein turnover analysis of a partial 15N stable isotope metabolic labelling experiment In Planta
    | PDF Version
  • Mauro Comes Franchini
    Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
    | PDF Version
  • Niren Murthy
    In vivo delivery of transcription factors with chemically modified oligonucleotides
    | PDF Version
  • W Wagner
    Tumor regression by means of magnetic drug targeting
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Naoya Tajima
    Quantum Hall effect in multilayered massless Dirac fermion systems
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Baharudin Ibrahim
    Personalizing drug treatment using pharmacometabonomic approach
    | PDF Version
  • Vladimir V Tolstikov
    Clinical Metabolomics: Case study CKD. Cross-platform omics data integration in Ingenuity Systems.
    | PDF Version
  • Richard Addo
    Ocular Delivery of peptides and proteins
    | PDF Version
  • Ruben Artero
    A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
    | PDF Version
  • Vladimir E. Bondarenko
    Mathematical model of 脙聨脗虏1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
    | PDF Version
  • Maria ISAGULIANTS
    DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
    | PDF Version
  • Grace London
    Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
    | PDF Version
  • Aina Westrheim Ravna
    Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
    | PDF Version
Conference Proceedings